UAE Begins Mapping Air Corridors for Air Taxis and Cargo Drones to Transform Urban Transportation
13.2.2025 18:12:00 CET | Business Wire | Press release
Initial advanced air mobility (AAM) regulations under development for the UAE GCAA and ATRC entities – TII and ASPIRE collaborate on technical expertise and airspace management
The UAE has taken a bold step towards redefining urban transportation with the commencement of air corridor mapping and regulatory framework development for piloted and autonomous air taxis and cargo drones. This transformative initiative marks a major leap forward in the nation’s mission to lead the future of mobility. Through a strategic partnership between the General Civil Aviation Authority (GCAA) and the Advanced Technology Research Council (ATRC) entities—Technology Innovation Institute (TII) and ASPIRE—the UAE is on track to reshape the way people and goods move through urban spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213996930/en/
UAE Begins Mapping Air Corridors for Air Taxis and Cargo Drones to Transform Urban Transportation (Photo: AETOSWire)
With aerial corridors and regulations set to be defined within the next 20 months, this pioneering effort demonstrates the UAE’s unwavering commitment to deploying safe, advanced, sustainable transportation solutions that will not only ease congestion but also set a global benchmark for future urban mobility systems. These routes will connect key international airports and iconic places in the UAE, extending further to ensure seamless integration of piloted and autonomous air taxis and cargo drones across the nation’s urban landscapes.
His Excellency Saif Mohammed Al Suwaidi, Director General of the GCAA said: “Air corridor mapping for piloted and autonomous air taxis and drones is a crucial milestone that will enable the seamless implementation of Advanced Air Mobility into the UAE’s infrastructure. This initiative ensures the safe and efficient adoption of air mobility, delivering transformative solutions to urban transport and paving the way for a smarter, more connected future.”
The UAE’s forward-thinking approach to urban transportation will be supported by TII’s expertise in airspace management, ensuring the safe integration of piloted and autonomous air taxis and cargo drones into urban environments. These new air corridors will offer innovative solutions for passenger and cargo transport, relieving pressure on traditional road networks and improving connectivity.
Dr. Najwa Aaraj, CEO of TII, said: “This transformative collaboration with GCAA is reshaping the future of urban transportation. By advancing airspace management and integrating piloted and autonomous air taxis and cargo drones, we are not only enhancing urban connectivity but also driving sustainable and accessible mobility solutions that will benefit future generations.”
Stephane Timpano from ASPIRE said: “Addressing real-time urban mobility challenges through innovative solutions like air taxis and drones is a major step forward. This initiative directly supports sustainable economic growth by creating a flexible and diverse transport system that eases pressure on urban infrastructure and fosters smarter, more resilient cities.”
The agreement was announced during World Governments Summit 2025.
Advanced Air Mobility (AAM) refers to the use of automated aircraft in urban and suburban settings to deliver innovative transport solutions for people and goods. With TII at the helm of developing the technical aspects of AAM and ASPIRE focusing on creating a network of stakeholders, including regulators, industry leaders, and researchers, this collaboration aims to establish a comprehensive regulatory framework that ensures safety and operational efficiency.
Prof. Enrico Natalizio, Chief Researcher of the Autonomous Robotics Research Center at TII, commented: “At TII, we’re developing advanced AI-powered control, vision and communication algorithms for autonomous systems that enable real-time decision-making for air taxis and drones. Having mastered this technology, we are able to propose methodologies for AAM corridors design to optimize routes, ensure collision avoidance, and integrate seamlessly with urban airspace, marking a key step toward efficient and safe autonomous air mobility in complex urban environments.”
Together with GCAA, these entities will define the airspace regulations and develop airspace management systems, making the UAE a global benchmark for advanced urban mobility.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213996930/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom